Overview Nicotinic Receptors and Schizophrenia Status: Completed Trial end date: 2014-10-01 Target enrollment: Participant gender: Summary The study determines if a new preparation of a drug designed to treat schizophrenia is more slowly released into the body. Phase: Phase 1 Details Lead Sponsor: VA Office of Research and Development